Pfizer announced on Wednesday that its vaccine trial has been completed, with “95% effectiveness.” The high success rate of the large-scale clinical tests is expected to bring coronavirus under control. Pfizer’s BNT162b2 vaccine is one the leading coronavirus vaccine candidates. It was developed by Pfizer and BioNTech. Officials said results will be submitted for regulatory approval […]
Please enter your email to receive our newsletter